Login / Signup

RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain.

Laura Basterretxea BadiolaNuria Lainez MilagroDiego Cacho LavínSandra López PeraitaMikel Arruti IbarbiaMireia Martínez KareagaTeresa de Portugal Fernández Del RiveroDiego Soto de Prado OteroValentín Alija LópezCarlos Álvarez FernándezAlejandra Lacalle EmborujoIrene Gil ArnaizRicardo Fernández RodríguezJuan Verdún-AguilarNaiara SagastibeltzaIgnacio Durannull null
Published in: Seminars in oncology (2024)
The Real-World Data on the management of mRCC in Northern Spain are comparable in epidemiology, efficacy, and safety to studies conducted in other areas of the world. The significant reduction in the number of patients receiving second and subsequent lines of therapy hampers the access to new therapies developed in this context.
Keyphrases
  • metastatic renal cell carcinoma
  • risk factors
  • stem cells
  • combination therapy
  • free survival
  • cell therapy